A phase I/II clinical study of deliverability and efficacy of high dose lenalidomide for the treatment of adult patients with acute lymphoblastic leukaemia.
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Lenalidomide (Primary) ; Lenalidomide (Primary) ; Dexamethasone
- Indications Acute lymphoblastic leukaemia
- Focus Therapeutic Use
- 10 Oct 2013 Status changed from recruiting to not yet recruiting as reported by Australian New Zealand Clinical Trials Registry record.
- 14 Sep 2013 New trial record